KREHER NERISSA - Insider Non-Derivative Transactions at Entrada Therapeutics, Inc. (TRDA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 6, 2023, KREHER NERISSA's relationship to Entrada Therapeutics, Inc. (TRDA) is Officer (Chief Medical Officer), and currently has 40,058 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TRDA insiders.

Data Source: SEC.
KREHER NERISSA - Insider Non-Derivative Transactions of TRDA Common Stock
KREHER NERISSA - Insider Non-Derivative Transactions at TRDA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 7, 2023 Sell -- (Common Stock) 21 14 40037
Sep 7, 2023 Sell -- (Common Stock) 871 13.46 40058
Sep 6, 2023 F -- (Common Stock) 401 14.46 40929
Sep 2, 2023 Acquisition -- (Common Stock) 14200 0 41330
Aug 5, 2023 Sell -- (Common Stock) 6898 14.14 27130
Aug 5, 2023 M -- (Common Stock) 6898 2.1 34028
Aug 4, 2023 Sell -- (Common Stock) 9464 14.74 27130
Aug 4, 2023 M -- (Common Stock) 9464 2.1 36594
Aug 3, 2023 Sell -- (Common Stock) 68 16.82 27130
Aug 3, 2023 Sell -- (Common Stock) 1000 16.01 27198
Aug 3, 2023 Sell -- (Common Stock) 9280 15.09 28198
Aug 3, 2023 M -- (Common Stock) 10348 2.1 37478
Mar 3, 2023 Sell -- (Common Stock) 164 11.22 41330
Mar 3, 2023 Sell -- (Common Stock) 1477 10.49 41494
Mar 3, 2023 F -- (Common Stock) 945 11.6 42971
Mar 2, 2023 Acquisition -- (Common Stock) 14200 0 27130
Mar 2, 2023 Acquisition -- (Common Stock) 28400 0 43916
Dec 31, 2022 Sell -- (Common Stock) 5200 13.45 15516